ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Order Full text via Infotrieve
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kaptein, A.
Right arrow Articles by Sluiter, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaptein, A.
Right arrow Articles by Sluiter, H.
Eur Respir J 1993; 6: 1479-1484
Copyright © ERS Journals Ltd 1993

Original Articles

Quality-of-life in a long-term multicentre trial in chronic nonspecific lung disease: assessment at baseline. The Dutch CNSLD Study Group

AA Kaptein, PL Brand, FW Dekker, HA Kerstjens, DS Postma, and HJ Sluiter

Quality-of-life (QOL) in patients with respiratory illness is a topic of increasing interest to clinicians and researchers. In a multicentre trial, which studies the long-term effects of three medication regimens (beta-agonist plus either placebo, anticholinergic agent or corticosteroid, all by inhalation) in patients with chronic nonspecific lung disease ((CNSLD): asthma and chronic obstructive pulmonary disease (COPD)), quality-of-life was included as an additional outcome measure. We wanted to provide a baseline assessment of quality-of-life in 274 adult patients with a mild to moderate degree of CNSLD. Quality-of-life was measured using a set of six standardized tests: Anxiety, Depression and Sleep Disorders, Optimism and Stigma, and Activities of Daily Living were assessed via scales with adequate validity and reliability, as established in previous work in Dutch patients with CNSLD. We found that quality-of-life was mildly impaired in these patients. Although differences with a reference group were present throughout, these were not significant, probably due to selection of relatively young, clinically stable, and highly motivated patients for our study. Quality-of-life scores showed higher correlation coefficients (0.20 < r < 0.38) to symptom scores than did results of pulmonary function tests (r < 0.015). In logistic regression models, absence from work and hospitalizations due to CNSLD were partly determined by quality-of-life scores.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
 ChestHome page
G. Xie, Y. Li, P. Shi, B. Zhou, P. Zhang, and Y. Wu
Baseline Pulmonary Function and Quality of Life 9 Years Later in a Middle-Aged Chinese Population
Chest, October 1, 2005; 128(4): 2448 - 2457.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
M. T. Britto, U. R. Kotagal, R. W. Hornung, H. D. Atherton, J. Tsevat, and R. W. Wilmott
Impact of Recent Pulmonary Exacerbations on Quality of Life in Patients With Cystic Fibrosis
Chest, January 1, 2002; 121(1): 64 - 72.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
D Staab, K Wenninger, N Gebert, K Rupprath, S Bisson, M Trettin, K D Paul, K M Keller, and U Wahn
Quality of life in patients with cystic fibrosis and their parents: what is important besides disease severity?
Thorax, September 1, 1998; 53(9): 727 - 731.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
C. Leonard, V. Tormey, C. Burke, and L. W. Poulter
Allergen-induced Cytokine Production in Atopic Disease and Its Relationship to Disease Severity
Am. J. Respir. Cell Mol. Biol., September 1, 1997; 17(3): 368 - 375.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the European Respiratory Society.